Literature DB >> 16425380

Effect of bombesin and neurotensin on gut barrier function in partially hepatectomized rats.

Stelios F Assimakopoulos1, Ilias H Alexandris, Chrisoula D Scopa, Panagiotis G Mylonas, Konstantinos C Thomopoulos, Christos D Georgiou, Vassiliki N Nikolopoulou, Constantine E Vagianos.   

Abstract

AIM: To investigate the effect of regulatory peptides bombesin (BBS) and neurotensin (NT) on intestinal barrier function in partially hepatectomized rats.
METHODS: Ninety male Wistar rats were randomly divided into five groups: I (n=0): controls, II (n= 20): sham operated, III (n=20): partial hepatectomy 70% (PHx), IV (n=20): PHx+BBS (30 microg/kg/d), V (n=20): PHx+NT (300 microg/kg/d). Groups IV and V were treated for 8 days before PHx and 48 h post surgery. At the end of the experiment, on day 10, intestinal barrier function was assessed by measuring endotoxin concentrations in portal and aortic blood. Tissue sections of the terminal ileum were examined histologically and villus density, mucosal thickness, mitotic activity and apoptosis in crypts were assessed. In addition, ileal mucosa was analyzed for DNA and protein content and microbiological analysis was performed in cecal contents. To estimate intestinal oxidative stress, lipid peroxidation was determined on tissue homogenates from terminal ileum.
RESULTS: BBS or NT administration significantly reduced portal and systemic endotoxemia observed 48 h after partial hepatectomy. In hepatectomized rats (group III), a trend towards induction of mucosal atrophy was observed, demonstrated by the reduction of villus density, mucosal thickness, protein content and significant reduction of DNA, while these alterations were reversed by regulatory peptides administration. This trophic effect of BBS and NT was accompanied by induction of mitoses above control levels and a significant reduction of apoptosis in intestinal crypts. Intestinal lipid peroxidation was found significantly lower in PHx group and regulatory peptides exerted an antioxidant action, further decreasing this parameter of oxidative stress. The bacterial population of E. coli and aerobic Gram (+) cocci was increased in cecal content of hepatectomized rats, while this parameter was not affected by the administration of BBS or NT.
CONCLUSION: Gut regulatory peptides BBS and NT improve intestinal barrier function and reduce endotoxemia in experimental partial hepatectomy. This effect is, at least in part, mediated by their trophic, anti-apoptotic, mitogenic, and antioxidant effect on the intestinal epithelium. This observation might be of potential value in patients undergoing liver resection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16425380      PMCID: PMC4725030          DOI: 10.3748/wjg.v11.i43.6757

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  45 in total

1.  Phosphorylation enhances mitochondrial targeting of GSTA4-4 through increased affinity for binding to cytoplasmic Hsp70.

Authors:  Marie-Anne Robin; Subbuswamy K Prabu; Haider Raza; Hindupur K Anandatheerthavarada; Narayan G Avadhani
Journal:  J Biol Chem       Date:  2003-03-19       Impact factor: 5.157

2.  Specific localisation of neurotensin to the N cell in human intestine by radioimmunoassay and immunocytochemistry.

Authors:  J M Polak; S N Sullivan; S R Bloom; A M Buchan; P Facer; M R Brown; A G Pearse
Journal:  Nature       Date:  1977-11-10       Impact factor: 49.962

3.  Pathology of human intestinal transplantation.

Authors:  R G Lee; K Nakamura; A C Tsamandas; K Abu-Elmagd; H Furukawa; W R Hutson; J Reyes; J S Tabasco-Minguillan; S Todo; A J Demetris
Journal:  Gastroenterology       Date:  1996-06       Impact factor: 22.682

4.  Intestinal bacterial overgrowth and bacterial translocation in cirrhotic rats with ascites.

Authors:  C Guarner; B A Runyon; S Young; M Heck; M Y Sheikh
Journal:  J Hepatol       Date:  1997-06       Impact factor: 25.083

5.  beta-Carotene production and its role in sclerotial differentiation of Sclerotium rolfsii.

Authors:  C D Georgiou; G Zervoudakis; N Tairis; M Kornaros
Journal:  Fungal Genet Biol       Date:  2001-10       Impact factor: 3.495

6.  Neurotensin binding sites in porcine jejunum: biochemical characterization and intramural localization.

Authors:  V S Seybold; B G Treder; L M Aanonsen; A Parsons; D R Brown
Journal:  Synapse       Date:  1990       Impact factor: 2.562

7.  Nonabsorbable antibiotics reduce bacterial and endotoxin translocation in hepatectomised rats.

Authors:  S K Kakkos; J Kirkilesis; C D Scopa; A Arvaniti; T Alexandrides; C E Vagianos
Journal:  HPB Surg       Date:  1997

8.  Bacterial translocation, intestinal ultrastructure and cell membrane permeability early after major liver resection in the rat.

Authors:  X D Wang; H Pärsson; R Andersson; V Soltesz; K Johansson; S Bengmark
Journal:  Br J Surg       Date:  1994-04       Impact factor: 6.939

9.  Bombesin stimulates mucosal growth in jejunal and ileal Thiry-Vella fistulas.

Authors:  K U Chu; S Higashide; B M Evers; J Ishizuka; C M Townsend; J C Thompson
Journal:  Ann Surg       Date:  1995-05       Impact factor: 12.969

10.  Liver failure induces a systemic inflammatory response. Prevention by recombinant N-terminal bactericidal/permeability-increasing protein.

Authors:  M A Boermeester; A P Houdijk; S Meyer; M A Cuesta; B J Appelmelk; R I Wesdorp; C E Hack; P A Van Leeuwen
Journal:  Am J Pathol       Date:  1995-11       Impact factor: 4.307

View more
  9 in total

1.  Enterocytes' tight junctions: From molecules to diseases.

Authors:  Stelios F Assimakopoulos; Ismini Papageorgiou; Aristidis Charonis
Journal:  World J Gastrointest Pathophysiol       Date:  2011-12-15

2.  Pleiotropic effects of bombesin and neurotensin on intestinal mucosa: not just trefoil peptides.

Authors:  Stelios-F Assimakopoulos; Chrisoula-D Scopa; Vassiliki-N Nikolopoulou; Constantine-E Vagianos
Journal:  World J Gastroenterol       Date:  2008-06-14       Impact factor: 5.742

3.  Effects of a gastrin-releasing peptide receptor antagonist on D-amphetamine-induced oxidative stress in the rat brain.

Authors:  Samira S Valvassori; Morgana Moretti; Marcia Kauer-Sant'Anna; Rafael Roesler; Fabrícia Petronilho; Gilberto Schwartsmann; Flavio Kapczinski; Felipe Dal-Pizzol; João Quevedo
Journal:  J Neural Transm (Vienna)       Date:  2010-02-04       Impact factor: 3.575

4.  Colonic enteric nervous system analysis during parenteral nutrition.

Authors:  Christopher S Erickson; Amanda J Barlow; Joseph F Pierre; Aaron F Heneghan; Miles L Epstein; Kenneth A Kudsk; Ankush Gosain
Journal:  J Surg Res       Date:  2013-03-16       Impact factor: 2.192

5.  Dynamic changes and mechanism of intestinal endotoxemia in partially hepatectomized rats.

Authors:  Cui-Ping Xu; Juan Liu; Jin-Chun Liu; De-Wu Han; Yang Zhang; Yuan-Chang Zhao
Journal:  World J Gastroenterol       Date:  2007-07-14       Impact factor: 5.742

Review 6.  Bombesin-related peptides and their receptors: recent advances in their role in physiology and disease states.

Authors:  Nieves Gonzalez; Terry W Moody; Hisato Igarashi; Tetsuhide Ito; Robert T Jensen
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2008-02       Impact factor: 3.243

Review 7.  International Union of Pharmacology. LXVIII. Mammalian bombesin receptors: nomenclature, distribution, pharmacology, signaling, and functions in normal and disease states.

Authors:  R T Jensen; J F Battey; E R Spindel; R V Benya
Journal:  Pharmacol Rev       Date:  2007-11-30       Impact factor: 25.468

8.  Adipose Tissue-Derived Biomarkers of Intestinal Barrier Functions for the Characterization of Diarrhoea-Predominant IBS.

Authors:  Francesco Russo; Guglielmina Chimienti; Giuseppe Riezzo; Michele Linsalata; Benedetta D'Attoma; Caterina Clemente; Antonella Orlando
Journal:  Dis Markers       Date:  2018-11-28       Impact factor: 3.434

9.  The anti-apoptotic role of neurotensin.

Authors:  Christelle Devader; Sophie Béraud-Dufour; Thierry Coppola; Jean Mazella
Journal:  Cells       Date:  2013-03-04       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.